256 related articles for article (PubMed ID: 25911316)
1. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections.
Dhamija RK; Tan H; Philbin E; Mathew RO; Sidhu MS; Wang J; Saour B; Haqqie SS; Beathard G; Yevzlin AS; Salman L; Boden WE; Siskin G; Asif A
Am J Kidney Dis; 2015 Jul; 66(1):154-8. PubMed ID: 25911316
[TBL] [Abstract][Full Text] [Related]
2. [Superior vena cava syndrome unrelated to central venous catheter in a patient on chronic hemodialysis].
Veronesi M; Mancini E; Salvati F; Santoro A
G Ital Nefrol; 2011; 28(4):436-40. PubMed ID: 21809314
[TBL] [Abstract][Full Text] [Related]
3. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
Kusztal M; Nowak K
J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.
Bakken AM; Protack CD; Saad WE; Lee DE; Waldman DL; Davies MG
J Vasc Surg; 2007 Apr; 45(4):776-83. PubMed ID: 17398386
[TBL] [Abstract][Full Text] [Related]
5. Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: A prospective multicenter study.
Campbell M; Moore JP; Sreeram N; von Alvensleben JC; Shah A; Batra A; Law I; Sanatani S; Thomas V; Nik-Ahd F; Williams S; Nosavan N; Maldonado J; Hart A; Nguyen T; Balaji S
Heart Rhythm; 2018 May; 15(5):703-707. PubMed ID: 29309839
[TBL] [Abstract][Full Text] [Related]
6. Proximal venous outflow obstruction in patients with upper extremity arteriovenous dialysis access.
Criado E; Marston WA; Jaques PF; Mauro MA; Keagy BA
Ann Vasc Surg; 1994 Nov; 8(6):530-5. PubMed ID: 7865390
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions.
Saad TF; Ahmed W; Davis K; Jurkovitz C
Semin Dial; 2015; 28(1):94-100. PubMed ID: 24863543
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous implantable cardioverter-defibrillator: Initial experience.
Galvão P; Cavaco D; Adragão P; Costa F; Carmo P; Morgado F; Bernardo R; Nunes M; Abecasis M; Neves J; Mendes M
Rev Port Cardiol; 2014 Sep; 33(9):511-7. PubMed ID: 25242675
[TBL] [Abstract][Full Text] [Related]
9. Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease?
O'Shaughnessy MM; Lappin DW; Reddan DN
Semin Dial; 2012 May; 25(3):272-6. PubMed ID: 22452711
[TBL] [Abstract][Full Text] [Related]
10. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
[TBL] [Abstract][Full Text] [Related]
11. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access.
Jaroszewski DE; Altemose GT; Scott LR; Srivasthan K; Devaleria PA; Lackey J; Arabia FA
Ann Thorac Surg; 2009 Jul; 88(1):112-6. PubMed ID: 19559206
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.
Saad TF; Hentschel DM; Koplan B; Wasse H; Asif A; Patel DV; Salman L; Carrillo R; Hoggard J;
Semin Dial; 2013; 26(1):114-23. PubMed ID: 22891983
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
14. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
Sanghera R; Sanders R; Husby M; Bentsen JG
Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.
Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC
Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244
[TBL] [Abstract][Full Text] [Related]
16. The subcutaneous implantable cardioverter-defibrillator.
Grace A
Curr Opin Cardiol; 2014 Jan; 29(1):10-9. PubMed ID: 24284982
[TBL] [Abstract][Full Text] [Related]
17. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
18. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
Chatrath R; Porter CB; Ackerman MJ
Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
[TBL] [Abstract][Full Text] [Related]
19. Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population.
Leake AE; Yuo TH; Wu T; Fish L; Dillavou ED; Chaer RA; Leers SA; Makaroun MS
J Vasc Surg; 2015 Jul; 62(1):123-7. PubMed ID: 25769391
[TBL] [Abstract][Full Text] [Related]
20. An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart.
Kowalski M; Nicolato P; Kalahasty G; Kasirajan V; Wood MA; Ellenbogen KA; Shepard RK
Heart Rhythm; 2010 Nov; 7(11):1572-7. PubMed ID: 20620234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
